Discover Nidra, now granted FDA market authorization with controlled release coming soon!

nidra logo RGB 1
Contact US
Do I qualify?
Contact US

Nidra is the first and only drug-free wearable therapy, clinically proven to reduce symptoms of Restless Leg Syndrome (RLS) when prescription medication is not providing relief.
Play Video
Play Video
50%-70% of people with RLS on the leading prescription drug therapy still experience worsening symptoms.
50%-70% of people with RLS on the leading prescription drug therapy still experience worsening symptoms.

1. Lipford MC, Silber MH. Sleep Med. 2012;13(10):1280-1285. 2. Silver N, et al. Sleep Med. 2011;12(5):440-444. 3. Meyers J, et al. Manag Care. 2012;21(10):44-51. 4. Kushida CA, et al. Neurology. 2009;72(5):439-446.

Nidra TOMAC Therapy

  • Non-invasive, drug-free wearable therapy
  • Relief from symptoms in as little as 30 minutes1
  • Personalized, adjustable, and sleep compatible
Learn How Nidra Works

1. Buchfuhrer MJ et al. J Clin Sleep Med. 2021;17(8):1685-1694.

Clinically
Proven Relief

The safety and efficacy of Nidra was evaluated in people with moderate-severe RLS who are resistant to medications in the RESTFUL study and in a subsequent 6-month extension study.1,2

60 %
of people

reported an
improvement in
their symptoms
over 8 weeks.

60 %
of people

reported acute
improvement in their
symptoms following
individual sessions.

0
additional days

symptom-free
per month.

Nidra provides relief with ZERO serious device-related adverse events reported at 6 months.

1. Safety and efficacy were determined based on enrollment of 133 participants in the RESTFUL study and 44 participants in the 6-month extension study.
2. Noctrix Health. Data on File. CL-10 Report, Analysis of acute relief from NTX100 TOMAC.

Fall asleep fast.
Wake rested.

Reclaim your nights
with Nidra

If prescription medications aren’t bringing you relief, talk with your doctor about Nidra, the drug-free solution to manage your RLS symptoms.

89%

of people reported an improvement
in their symptoms over 8 weeks.

of people reported an improvement
in their symptoms over 8 weeks.

Contact Us

Please enable JavaScript in your browser to complete this form.
Multiple Choice

Contact Us

Please enable JavaScript in your browser to complete this form.
Multiple Choice
Please see
Important Safety Information
and
Indications For Use

INDICATION
The NTX100 Tonic Motor Activation (TOMAC) System is intended to reduce symptoms of primary moderate-severe Restless Legs Syndrome and to improve sleep quality in adults refractory to medications.*

Rx Only. Caution: Federal law restricts this device to sale by or on the order of a medical professional.
*FDA De Novo Number DEN220059

© 2023 Noctrix Health, Inc. All rights reserved.

MKT-8 Rev 2.0

noctrix logo horiz RGB white

All information on this website is provided for informational purposes only and is not intended to be a substitute for any professional medical advice or any medical diagnosis or treatment. Nidra is intended for prescription use only and is only available for commercial sale in the United States by or on the order of a physician. Individual patient experience may vary.

Important Safety Information

IMPORTANT SAFETY INFORMATION
Contraindications
The Nidra TOMAC System is contraindicated for use in patients with the following:

  • Diagnosis of epilepsy or other seizure disorder
  • Active medical device implant anywhere in the body, including but not limited to pacemakers, spinal cord stimulators, deep brain stimulators
  • Metal implant in the leg at the therapy site (not including knee replacements)
  • Known allergy to device materials (or severe previous reaction to medical adhesives or bandages)
  • Cellulitis, open sores, or injury at or near the location of therapy device application
  • The device cannot be used while driving, operating machinery, or during any activity in which electrical stimulation can put the patient at risk of injury

Potential Complications
There is a potential for the following side effects, which are typically mild to moderate and resolve over time:

  • Mild skin irritation from use of adhesives.
  • Temporary interference with sleep while wearing the device. For some people, the device may be uncomfortable. For others, the device may interfere with preferred sleep positions.
  • Proper use of the device as described in the Instructions for Use (IFU) can help reduce or prevent the following complications: Discomfort, paresthesia (tingling or prickling sensation), or otherwise irritating or uncomfortable sensations during treatment. This risk is reduced by adjusting the stimulation intensity.

This list is not all inclusive. Please refer to the Instructions for Use. for all of the important warnings and precautions before using or prescribing this product.